CREB1 and clear cell sarcoma: Further studies with larger cohorts are necessary to explore the full epigenetic spectrum of IMT, FET::CREB fusion-positive and its relationship to AFH, clear cell sarcoma, solitary fibrous tumor, meningioma, and the other tumors.